Gierlikowska Barbara, Filipek Agnieszka, Gierlikowski Wojciech, Kania Dominika, Stefańska Joanna, Demkow Urszula, Kiss Anna K
Department of Laboratory Diagnostics and Clinical Immunology of Developmental Age, Medical University of Warsaw, Warsaw, Poland.
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Warsaw, Poland.
Front Pharmacol. 2021 Jan 18;11:534111. doi: 10.3389/fphar.2020.534111. eCollection 2020.
Both nasal and bronchial epithelial cells have evolved sophisticated mechanisms involved in cellular response to bacterial infection. Recognition of pathogens by TLR receptors activate the NF-κB transcription factor, and lead to production of wide spectrum of cytokines (TNF-α, IL-1β, IL-6 and IL-8). Released by epithelium proinflammatory cytokines intensify migration of macrophages to damaged tissues and modulate their pro-inflammatory functions. Based on traditional use of aerial parts we hypothesized that successful treatment of cold-related diseases may arise from modulation of the pro-inflammatory functions of respiratory epithelium and human monocytes/macrophages. The biological activity of extract and grindelic acid were compared with clarithromycin and budesonide used as positive controls. The expression of surface receptors (TLR-4, IL-10) and expression of adhesive molecules (ICAM-1, VCAM-1, E-selectin) was analyzed with flow cytometry. The macrophage attachment to the epithelial cells was assessed fluorimetrically. The p65 NF-κB concentration and cytokine production was measured spectrophotometrically using enzyme-linked immunosorbent assay. Antibacterial activity was examined by the standard disc-diffusion method and serial dilution method according to CLSI guidelines. extract and grindelic acid had no antimicrobial effect. However, we noticed significant modulation of pro-inflammatory functions of LPS-stimulated nasal and bronchial epithelium. extract treatment resulted in decrease of TLR-4 expression and p65 NF-κB concentration and inhibition of cytokines synthesis (IL-8, TNF-α, IL-1β and IL-6) in both cellular models. Additionally, extract slightly modulated ICAM-1 expression affecting on attachment of macrophages to epithelium. Only extract was able to stimulate the anti-inflammatory functions of macrophages by inducing TGF-β release and IL-10 receptor surface expression. Grindelic acid, identified as a dominant compound in the plant extract, modulated pro-inflammatory functions of epithelium and macrophages slightly. The obtained results support traditional use of preparations for a treatment cold-associated diseases symptoms. In our opinion, the observed biological effect of extract may be a consequence of synergistic effect of all compounds present in the extract.
鼻上皮细胞和支气管上皮细胞都进化出了复杂的机制来参与细胞对细菌感染的反应。Toll样受体(TLR)对病原体的识别会激活核因子-κB(NF-κB)转录因子,并导致多种细胞因子(肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6和白细胞介素-8)的产生。上皮细胞释放的促炎细胞因子会增强巨噬细胞向受损组织的迁移,并调节其促炎功能。基于地上部分的传统用途,我们推测成功治疗与感冒相关的疾病可能源于对呼吸道上皮细胞和人类单核细胞/巨噬细胞促炎功能的调节。将提取物和格氏酸的生物活性与用作阳性对照的克拉霉素和布地奈德进行了比较。用流式细胞术分析表面受体(TLR-4、白细胞介素-10)的表达以及黏附分子(细胞间黏附分子-1、血管细胞黏附分子-1、E-选择素)的表达。通过荧光分析法评估巨噬细胞与上皮细胞的附着情况。使用酶联免疫吸附测定法通过分光光度法测量p65 NF-κB浓度和细胞因子的产生。根据美国临床和实验室标准协会(CLSI)指南,采用标准纸片扩散法和系列稀释法检测抗菌活性。提取物和格氏酸没有抗菌作用。然而,我们注意到脂多糖刺激的鼻上皮细胞和支气管上皮细胞的促炎功能有显著调节。提取物处理导致两种细胞模型中TLR-4表达和p65 NF-κB浓度降低,并抑制细胞因子合成(白细胞介素-8、肿瘤坏死因子-α、白细胞介素-1β和白细胞介素-6)。此外,提取物轻微调节细胞间黏附分子-1的表达,影响巨噬细胞与上皮细胞的附着。只有提取物能够通过诱导转化生长因子-β释放和白细胞介素-10受体表面表达来刺激巨噬细胞的抗炎功能。格氏酸被确定为植物提取物中的主要化合物,对上皮细胞和巨噬细胞的促炎功能有轻微调节作用。所得结果支持了该制剂用于治疗感冒相关疾病症状的传统用途。我们认为,提取物观察到的生物学效应可能是提取物中所有化合物协同作用的结果。